Short term outcomes of Endoscopic Pilonidal Sinus Treatment (EPSiT)
Endoscopic Pilonidal Sinus Treatment
Endoscopic treatment of pilonidal disease (EPSiT) was initially described by Meinero in 2013. This minimally invasive technique has both technical and aesthetic advantages. The diagnostic application helps identify the anatomy of the pilonidal disease and the operative phase ablates and cleans the infected cavity. Our aim was to study the short-term outcomes of EPSiT and evaluate complications and recurrence rates
Prospectively maintained database of all consecutive patients who underwent EPSiT by a single surgeon in a District General Hospital from 01/11/2014 to 31/03/2018 were analysed. Follow-up was available until 30/09/2018. Data are presented as median (range).
74 (56 males) patients underwent EPSiT. Median age was 21 (16-62) years. All patients underwent EPSiT as day case procedures of which 7 patients had under local anaesthesia. There were no immediate postoperative complications, return to theatre or re-admissions within 90 days. On a median follow-up of 52 (2-114) weeks, 57 patients healed completely, and 8 patients were lost to follow-up. We achieved primary healing rates of 67% (44/66) and delayed healing rate of 77% (51/66) with EPSiT.
EPSiT is a safe, effective, minimally invasive technique that should be considered as first-line treatment in selected cases of pilonidal sinus disease, thereby reducing morbidity related to conventional procedures.